In community-acquired pneumonia, can steroids improve mortality? Past studies of steroids in CAP have been conflicting, with some showing a mortality benefit and others showing no difference. How does the CAPE COD trial change how we think about patients hospitalized with severe CAP? To find out, tune into the third episode of Beyond Journal Club, a new series brought to you by Core IM in collaboration with NEJM Group.
Podden och tillhörande omslagsbild på den här sidan tillhör Core IM Team. Innehållet i podden är skapat av Core IM Team och inte av, eller tillsammans med, Poddtoppen.
